Crossmark

A mass spectrometry-based proteome map of drug action in lung cancer cell lines

Published Online: 2020-07-20

Published Print: 2020-10

Authors

Ruprecht, Benjamin http://orcid.org/0000-0001-9807-5825
Di Bernardo, Julie

Wang, Zhao

Mo, Xuan http://orcid.org/0000-0001-8638-6482
Ursu, Oleg

Christopher, Matthew

Fernandez, Rafael B.

Zheng, Li

Dill, Brian D. http://orcid.org/0000-0002-4532-3044
Wang, Huijun

Xu, Yuting http://orcid.org/0000-0003-2091-3854
Liaw, Andy

Mortison, Jonathan D.

Siriwardana, Nirodhini

Andresen, Brian

Glick, Meir

Tata, James R.

Kutilek, Victoria

Cornella-Taracido, Ivan

Chi, An http://orcid.org/0000-0002-8213-1826
License Information

Text and Data Mining valid from 2020-07-20

Version of Record valid from 2020-07-20
More Information

Article History

Received: 6 August 2019

Accepted: 22 May 2020

First Online: 20 July 2020

Competing interests

: All authors are or were employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.

Document is current